State of Wisconsin Investment Board’s Xeris Biopharma Holdings XERS Stock Holding History

State of Wisconsin Investment Board’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.79M	Sell	308,546 -48,907	-14%	-$324K	﹤0.01%	1445
2025 Q4	$2.81M	Buy	357,453 +6,924	+2%	+$54.5K	0.01%	1267
2025 Q3	$2.85M	Buy	350,529 +72,509	+26%	+$482K	0.01%	1199
2025 Q2	$1.3M	Buy	278,020 +257,745	+1,271%	+$1.18M	﹤0.01%	1479
2025 Q1	$111K	Buy	+20,275	New	+$81.8K	﹤0.01%	2168
2021 Q2	–	Sell	-64,800	Closed	-$292K	–	2173
2021 Q1	$292K	Hold	64,800	–	–	﹤0.01%	1902
2020 Q4	$319K	Buy	+64,800	New	+$324K	﹤0.01%	1789
2020 Q3	–	Sell	-14,300	Closed	-$38K	–	1991
2020 Q2	$38K	Buy	+14,300	New	+$49.8K	﹤0.01%	1706
2020 Q1	–	Sell	-40,000	Closed	-$282K	–	1742
2019 Q4	$282K	Hold	40,000	–	–	﹤0.01%	1552
2019 Q3	$393K	Buy	40,000 +10,400	+35%	+$117K	﹤0.01%	1396
2019 Q2	$339K	Buy	+29,600	New	+$311K	﹤0.01%	1418

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State of Wisconsin Investment Board's XERS Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its Xeris Biopharma Holdings (XERS) stake by 14% in Q1 2026, selling an estimated $324K and leaving 308,546 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1445.

State of Wisconsin Investment Board first reported a position in XERS in Q2 2019 and has held it in 11 quarters since. The position peaked at $2.85M in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

State of Wisconsin Investment Board held 308,546 shares of Xeris Biopharma Holdings worth $1.79M as of Q1 2026.
State of Wisconsin Investment Board sold 48,907 Xeris Biopharma Holdings shares in Q1 2026, an estimated $324K.
Xeris Biopharma Holdings made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1445 holding.
State of Wisconsin Investment Board first reported a position in Xeris Biopharma Holdings in Q2 2019 and has held it in 11 quarters since.
State of Wisconsin Investment Board's Xeris Biopharma Holdings position peaked at $2.85M in Q3 2025.
237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.